Drug Evaluation Assistant
Built for HTA committee members and formulary decision-makers to deliver detailed technical and clinical/economic evaluation packages for drugs under consideration for reimbursement and formulary listing.
Automated searching and comprehensive reporting with GRADE and CASP quality assessment, delivering actionable insights for reimbursement decisions.
Comprehensive disease burden assessment and epidemiological context for informed decision-making
Basic prescribing information including dosing, administration, and key product characteristics
Detailed summary tables of published relevant clinical evidence and trial outcomes
Comprehensive cost-effectiveness analysis and pharmacoeconomic evidence for budget impact
Direct grading of evidence level and quality assessment using GRADE and CASP checklists
Summaries of published HTA reports from internationally recognized agencies worldwide
Purpose-built for HTA committees and formulary decision-makers to streamline reimbursement evaluation with evidence-based automation.
Targeted searching by drug name and indication for precise, relevant results
Rigorous GRADE and CASP checklist assessment for evidence quality validation
Full evaluation packages covering clinical, economic, and HTA agency perspectives
Access published reports from globally recognized HTA agencies in one place
Select from two comprehensive report options tailored to your specific needs.
Complete automated analysis covering all seven sections
Most PopularEst. Time: 15-20 minutes
AI-generated report with expert human review and validation
Expert ReviewEst. Time: 2-3 business days
Join HTA committees and formulary decision-makers who rely on Lilly for comprehensive, evidence-based evaluation packages.